RhumbLine Advisers’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
225,548
+2,433
| +1% | +$22.6K | ﹤0.01% | 1860 |
|
|
2025
Q1 | $1.64M | Buy |
223,115
+9,514
| +4% | +$69.7K | ﹤0.01% | 1911 |
|
|
2024
Q4 | $1.82M | Buy |
213,601
+5,682
| +3% | +$48.5K | ﹤0.01% | 1933 |
|
|
2024
Q3 | $1.81M | Sell |
207,919
-3,382
| -2% | -$29.4K | ﹤0.01% | 1965 |
|
|
2024
Q2 | $1.45M | Buy |
211,301
+59,345
| +39% | +$406K | ﹤0.01% | 2053 |
|
|
2024
Q1 | $1.38M | Buy |
151,956
+37,991
| +33% | +$346K | ﹤0.01% | 2087 |
|
|
2023
Q4 | $508K | Sell |
113,965
-16,051
| -12% | -$71.6K | ﹤0.01% | 2648 |
|
|
2023
Q3 | $408K | Buy |
130,016
+7,793
| +6% | +$24.5K | ﹤0.01% | 2733 |
|
|
2023
Q2 | $631K | Buy |
122,223
+14,388
| +13% | +$74.2K | ﹤0.01% | 2542 |
|
|
2023
Q1 | $568K | Buy |
107,835
+6,492
| +6% | +$34.2K | ﹤0.01% | 2380 |
|
|
2022
Q4 | $285K | Buy |
101,343
+2,011
| +2% | +$5.66K | ﹤0.01% | 2693 |
|
|
2022
Q3 | $412K | Buy |
99,332
+8,837
| +10% | +$36.7K | ﹤0.01% | 2584 |
|
|
2022
Q2 | $364K | Buy |
90,495
+1,828
| +2% | +$7.35K | ﹤0.01% | 2654 |
|
|
2022
Q1 | $439K | Buy |
88,667
+1,549
| +2% | +$7.67K | ﹤0.01% | 2480 |
|
|
2021
Q4 | $607K | Sell |
87,118
-1,844
| -2% | -$12.8K | ﹤0.01% | 2428 |
|
|
2021
Q3 | $890K | Buy |
88,962
+3,845
| +5% | +$38.5K | ﹤0.01% | 2277 |
|
|
2021
Q2 | $1.21M | Buy |
85,117
+1,591
| +2% | +$22.6K | ﹤0.01% | 2156 |
|
|
2021
Q1 | $1.37M | Sell |
83,526
-2,189
| -3% | -$35.9K | ﹤0.01% | 2066 |
|
|
2020
Q4 | $1.77M | Buy |
85,715
+14,975
| +21% | +$310K | ﹤0.01% | 1909 |
|
|
2020
Q3 | $538K | Sell |
70,740
-5,655
| -7% | -$43K | ﹤0.01% | 2255 |
|
|
2020
Q2 | $636K | Buy |
76,395
+19,141
| +33% | +$159K | ﹤0.01% | 2236 |
|
|
2020
Q1 | $283K | Buy |
57,254
+1,544
| +3% | +$7.63K | ﹤0.01% | 2433 |
|
|
2019
Q4 | $220K | Buy |
55,710
+4,864
| +10% | +$19.2K | ﹤0.01% | 2718 |
|
|
2019
Q3 | $155K | Buy |
50,846
+605
| +1% | +$1.84K | ﹤0.01% | 2810 |
|
|
2019
Q2 | $221K | Buy |
50,241
+8,017
| +19% | +$35.3K | ﹤0.01% | 2754 |
|
|
2019
Q1 | $168K | Sell |
42,224
-1,241
| -3% | -$4.94K | ﹤0.01% | 2789 |
|
|
2018
Q4 | $173K | Buy |
43,465
+14,551
| +50% | +$57.9K | ﹤0.01% | 2776 |
|
|
2018
Q3 | $199K | Sell |
28,914
-1,288
| -4% | -$8.87K | ﹤0.01% | 2731 |
|
|
2018
Q2 | $204K | Buy |
30,202
+7,255
| +32% | +$49K | ﹤0.01% | 2730 |
|
|
2018
Q1 | $149K | Buy |
22,947
+1,625
| +8% | +$10.6K | ﹤0.01% | 2669 |
|
|
2017
Q4 | $95K | Sell |
21,322
-8,513
| -29% | -$37.9K | ﹤0.01% | 2779 |
|
|
2017
Q3 | $184K | Buy |
29,835
+2,449
| +9% | +$15.1K | ﹤0.01% | 2769 |
|
|
2017
Q2 | $254K | Buy |
27,386
+4,958
| +22% | +$46K | ﹤0.01% | 2639 |
|
|
2017
Q1 | $208K | Buy |
22,428
+3,493
| +18% | +$32.4K | ﹤0.01% | 2642 |
|
|
2016
Q4 | $158K | Buy |
18,935
+5,651
| +43% | +$47.2K | ﹤0.01% | 2727 |
|
|
2016
Q3 | $91K | Buy |
13,284
+230
| +2% | +$1.58K | ﹤0.01% | 2818 |
|
|
2016
Q2 | $65K | Sell |
13,054
-1,900
| -13% | -$9.46K | ﹤0.01% | 2954 |
|
|
2016
Q1 | $144K | Hold |
14,954
| – | – | ﹤0.01% | 2828 |
|
|
2015
Q4 | $140K | Buy |
14,954
+3,185
| +27% | +$29.8K | ﹤0.01% | 2894 |
|
|
2015
Q3 | $165K | Buy |
11,769
+1,444
| +14% | +$20.2K | ﹤0.01% | 2855 |
|
|
2015
Q2 | $217K | Buy |
+10,325
| New | +$217K | ﹤0.01% | 2848 |
|